Skip to main content

2 August 2013

Further to the announcement made on 31 May 2013 about a preliminary approach for the Medical division, Smiths Group announces that it has not proved possible to reach agreement with the potential counterparty on acceptable terms for a transaction. Discussions have therefore been terminated.

In reaching this conclusion, the Board has taken full account of the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.

Related articles

Kini

Smiths Group appoints Kini Pathmanathan as Head of Smiths Excellence & Sustainability

Find out more Call to action arrow icon
Belfast City Airport

Smiths Detection to supply Belfast International Airport with 3D X-ray scanners

Find out more Call to action arrow icon
Diffraction (1)

Smiths Detection launches X-ray Diffraction technology to combat illegal narcotics and contraband trafficking  

Find out more Call to action arrow icon